Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Futamura

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Scientific Reports|October 12, 2019
Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort StudyTakahisa Hiramitsu, Toshihide Tomosugi, Manabu Okada, et al.
Transplantation Proceedings|March 16, 2025
Preoperative Calcimimetic Treatment may Prevent Serum Creatinine Elevation after Parathyroidectomy in Kidney Transplant Recipients: A Retrospective Cohort StudyManabu Okada, Shunji Narumi, Tetsuhiko Sato, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 16, 2024
Pre-Transplant Calcimimetic Use and Dose Information Improves the Accuracy of Prediction of Tertiary Hyperparathyroidism after Kidney Transplantation: A Retrospective Cohort StudyManabu Okada, Tetsuhiko Sato, Tomoki Himeno, et al.
Transplantation|March 12, 2025
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)Naotsugu Ichimaru, Yoichiro Natori, Rita R Alloway, et al.
Transplantation Proceedings|May 7, 2019
Everolimus-based Immunosuppression Possibly Suppresses Mean Fluorescence Intensity Values of De Novo Donor-specific Antibodies After Primary Kidney TransplantationShunji Narumi, Yoshihiko Watarai, Norihiko Goto, et al.
Human Immunology|December 16, 2018
Lower incidence of de novo donor-specific antibodies against HLA-DR in ABO-incompatible renal transplantationManabu Okada, Yoshihiko Watarai, Kenta Iwasaki, et al.
Clinical Transplantation|January 12, 2023
Optimal dose of rituximab in ABO-incompatible kidney transplantation in patients with low anti-A/B antibody titers: A single-center retrospective cohort studyManabu Okada, Shunji Narumi, Yuki Hasegawa, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2023
Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonists for Kidney Transplant Recipients With Type 2 DiabetesTetsuhiko Sato, Yoshinori Azuma, Chikafumi Ozone, et al.
Clinical and Experimental Nephrology|July 11, 2026
Early glomerular capillary C4d is associated with poor graft function in kidney transplant recipients with preformed donor-specific antibodiesYuki Shimamoto, Manabu Okada, Takahisa Hiramitsu, et al.
Renal Failure|March 24, 2025
Urinary Basigin/CD147 is a useful marker of acute T cell-mediated rejection in kidney transplant recipientsKenta Futamura, Makoto Tsujita, Tomoki Kosugi, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Scientific Reports|October 12, 2019
Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort StudyTakahisa Hiramitsu, Toshihide Tomosugi, Manabu Okada, et al.
Transplantation Proceedings|March 16, 2025
Preoperative Calcimimetic Treatment may Prevent Serum Creatinine Elevation after Parathyroidectomy in Kidney Transplant Recipients: A Retrospective Cohort StudyManabu Okada, Shunji Narumi, Tetsuhiko Sato, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 16, 2024
Pre-Transplant Calcimimetic Use and Dose Information Improves the Accuracy of Prediction of Tertiary Hyperparathyroidism after Kidney Transplantation: A Retrospective Cohort StudyManabu Okada, Tetsuhiko Sato, Tomoki Himeno, et al.
Transplantation|March 12, 2025
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)Naotsugu Ichimaru, Yoichiro Natori, Rita R Alloway, et al.
Transplantation Proceedings|May 7, 2019
Everolimus-based Immunosuppression Possibly Suppresses Mean Fluorescence Intensity Values of De Novo Donor-specific Antibodies After Primary Kidney TransplantationShunji Narumi, Yoshihiko Watarai, Norihiko Goto, et al.
Human Immunology|December 16, 2018
Lower incidence of de novo donor-specific antibodies against HLA-DR in ABO-incompatible renal transplantationManabu Okada, Yoshihiko Watarai, Kenta Iwasaki, et al.
Clinical Transplantation|January 12, 2023
Optimal dose of rituximab in ABO-incompatible kidney transplantation in patients with low anti-A/B antibody titers: A single-center retrospective cohort studyManabu Okada, Shunji Narumi, Yuki Hasegawa, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2023
Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonists for Kidney Transplant Recipients With Type 2 DiabetesTetsuhiko Sato, Yoshinori Azuma, Chikafumi Ozone, et al.
Clinical and Experimental Nephrology|July 11, 2026
Early glomerular capillary C4d is associated with poor graft function in kidney transplant recipients with preformed donor-specific antibodiesYuki Shimamoto, Manabu Okada, Takahisa Hiramitsu, et al.
Renal Failure|March 24, 2025
Urinary Basigin/CD147 is a useful marker of acute T cell-mediated rejection in kidney transplant recipientsKenta Futamura, Makoto Tsujita, Tomoki Kosugi, et al.
Pageof 7